Article Text

Download PDFPDF
Good news continues for JIM in 2021
  1. Richard McCallum
  1. Department of Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA
  1. Correspondence to Dr Richard McCallum, Internal Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas, USA; richard.mccallum{at}ttuhsc.edu

Statistics from Altmetric.com

Colleagues, I am writing to give you a mid-year progress report for the Journal of Investigative Medicine (JIM).

In the environment of ongoing COVID-19 challenges, with increasing clinical and/or administrative responsibilities for all researchers, JIM has continued to sustain the growth we witnessed in 2020. Here are some highlights for 2021 when compared with the data from June 2020.

  • There has been a steady increase in submissions over the past 2 years. Through June 2021, submissions have grown 50% versus the same time period in 2020 (figure 1).

  • The editorial team continues to work to improve the quality of JIM submissions, as evidenced by a decreased acceptance rate for all papers of 25% (figure 2).

  • Web traffic has been …

View Full Text

Footnotes

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.